Glioblastoma

Showing NaN - NaN of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

    Recruiting
    • Anaplastic Astrocytoma
    • +6 more
    • Biopsy
    • +3 more
    • Birmingham, Alabama
    • +62 more
    Feb 2, 2023

    Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)

    Active, not recruiting
    • Glioblastoma
    • Recurrent Glioblastoma
    • Boston, Massachusetts
    • +3 more
    Jan 13, 2023

    Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +2 more
    • Radiation Therapy
    • +2 more
    • Birmingham, Alabama
    • +162 more
    Dec 30, 2022

    Glioblastoma Trial in Boston, New York, Philadelphia (Pembrolizumab, Bevacizumab, Re-irradiation)

    Active, not recruiting
    • Glioblastoma
    • Boston, Massachusetts
    • +4 more
    Dec 7, 2022

    Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +5 more
    • RSC-1255 Dose Escalation
    • RSC-1255 Dose Expansion
    • Los Angeles, California
    • +5 more
    Oct 24, 2022

    Glioblastoma Trial in Canada, China, United States (drug, other, radiation)

    Active, not recruiting
    • Glioblastoma
    • Enzastaurin Hydrochloride
    • +3 more
    • Birmingham, Alabama
    • +62 more
    Oct 11, 2022

    Glioblastoma Trial in United States (biological, radiation, drug)

    Active, not recruiting
    • Glioblastoma
    • INO-5401
    • +4 more
    • Duarte, California
    • +20 more
    Aug 8, 2022

    Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

    Recruiting
    • Glioblastoma
    • Adult-type Diffuse Gliomas
    • Beverly Hills, California
    • +83 more
    Jul 25, 2022

    Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)

    Not yet recruiting
    • Glioblastoma Multiforme
    • Glioblastoma
    • IGV-001 Cell Immunotherapy
    • +3 more
    • Newark, Delaware
    • +22 more
    Jun 24, 2022

    Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

    Active, not recruiting
    • Glioblastoma Multiforme
    • +6 more
    • Dendritic cell immunotherapy
    • Birmingham, Alabama
    • +85 more
    May 12, 2022

    Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)

    Active, not recruiting
    • Glioblastoma
    • Birmingham, Alabama
    • +60 more
    Apr 4, 2022

    Glioblastoma Trial in Philadelphia (Radation Therapy)

    Recruiting
    • Glioblastoma
    • Radation Therapy
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Mar 31, 2022

    Glioblastoma Trial in Philadelphia (18F-FluorThanatrace)

    Recruiting
    • Glioblastoma
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jan 21, 2022

    Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)

    Recruiting
    • Glioblastoma
    • +2 more
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Jul 16, 2021

    Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,

    Recruiting
    • Glioblastoma
    • +2 more
    • Intensity-Modulated Radiation Therapy
    • Quality-of-Life
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021

    Glioblastoma Trial in Philadelphia (drug, radiation, device, procedure)

    Recruiting
    • Glioblastoma
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021

    Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)

    Terminated
    • Glioblastoma
    • +2 more
    • La Jolla, California
    • +10 more
    May 12, 2021

    Glioblastoma, Malignant Solid Tumor Trial in Philadelphia (Biospecimen Collection)

    Recruiting
    • Glioblastoma
    • Malignant Solid Neoplasm
    • Biospecimen Collection
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Mar 26, 2021

    Glioblastoma Trial in Philadelphia (CART-EGFRvIII T cells, Pembrolizumab)

    Completed
    • Glioblastoma
    • CART-EGFRvIII T cells
    • Pembrolizumab
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Mar 2, 2021

    Glioblastoma, Grade IV Astrocytoma, Glioblastoma Multiforme Trial in United States (MDNA55)

    Completed
    • Glioblastoma
    • +3 more
    • San Francisco, California
    • +6 more
    Jan 13, 2021

    Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,

    Completed
    • Glioblastoma
    • +2 more
    • 3-Dimensional Conformal Radiation Therapy
    • +6 more
    • Mobile, Alabama
    • +329 more
    Jul 22, 2019

    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,

    Completed
    • Glioblastoma
    • +4 more
    • Rindopepimut (CDX-110) with GM-CSF
    • +2 more
    • Birmingham, Alabama
    • +222 more
    Jan 11, 2018